by Madaline Spencer | Jun 23, 2025
Gideon Hirschfield, MD, of the Toronto General Hospital and Toronto Centre for Liver Disease, discusses results from the phase 3 GLISTEN trial in patients with primary biliary cholangitis (PBC). PBC is a chronic, progressive autoimmune liver disease in...
by Madaline Spencer | Jun 20, 2025
Claudia Sommer, MD, Professor of Neurology at the University of Würzburg, Germany, and Alex Seluzhytsky, MD, Senior Global Medical Director at Sanofi, discuss data on riliprubart for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). ...
by Madaline Spencer | Jun 19, 2025
Salomon Manier, MD, PhD, Associate Professor of Hematology at Lille University Hospital in France, discusses results from a phase 1b clinical trial evaluating linvoseltamab combination therapy in patients with relapsed/refractory multiple myeloma (MM). ...
by Madaline Spencer | Jun 18, 2025
The U.S. Food and Drug Administration (FDA) has approved Andembry (garadacimab) for the treatment of hereditary angioedema (HAE) in patients ages 12 years and older. Hereditary Angioedema HAE is a rare condition characterized by recurrent episodes of severe...
by Madaline Spencer | Jun 18, 2025
Leticia Orsatti, MD, Vice President of Clinical Development and Medical Affairs at Boehringer Ingelheim, discusses results from clinical trials examining the safety and efficacy of nerandomilast to treat patients with idiopathic pulmonary fibrosis (IPF) or progressive...
